Pharma
-
Delhi
India’s Diabetes Drug Market Shifts as Ozempic Enters at ₹2200 Per Dose, 9 Points
Bagsværd (Denmark) / Delhi Ozempic Launch in India: ₹2200/Week Diabetes Injection Signals ₹10000+ Monthly GLP-1 Market Shift |What ₹1.3 Lakh…
Read More » -
Market
Eli Lilly Becomes First Pharma Giant to Hit $1T Market Cap, 5 Points
Indianapolis (Indiana) / New York Eli Lilly Hits $1 Trillion Market Cap on Zepbound & Mounjaro Surge | Weight-Loss &…
Read More » -
Market
QS-21: The $400000-a-Gram Solution Reshaping Global Vaccines, 13 Points
Santiago (Chile) / New York Botanical Solution Inc’s (BSI) $400,000-a-gram Innovation: How Chile’s Agri-Biotech Powerhouse is Redefining Global Vaccine and…
Read More » -
Delhi
Eli Lilly Partners with Cipla to Tap ₹25000 Crore Obesity Market, 10 Points
Indianapolis (Indiana) / New York Cipla – Eli Lilly Partnership to Take ₹80-Crore Mounjaro (Tirzepatide) Beyond Metros — Targeting India’s…
Read More » -
Gujarat
Pankaj Patel’s ₹84510 Crore Fortune: Gujarat’s No 2 Richest After Adani, 6 Points
Ahmedabad Gujarat’s Pharma Powerhouse: Chairman of Zydus Lifesciences Pankaj Patel Ranks 2nd Richest Gujarati with ₹84,510 Crore Net Worth (Hurun…
Read More » -
Delhi
Eli Lilly Commits $1B+ to India Amid Global Pharma Realignment, 8 Points
New York / Delhi Eli Lilly’s $1 Billion+ Investment in India: A Strategic Manufacturing Boost 1. Investment Overview US pharmaceutical…
Read More » -
AI & Tech
India’s 168 SEZs Driving ₹8.5 Lakh Cr Exports, $100B+ FDI, 9 Points
1. Special Economic Zones (SEZs) – Financial Backbone of Indian Growth 1.1 Policy Foundation – Established under the SEZ Act,…
Read More »